Prosecution Insights
Last updated: April 19, 2026

Immunogen Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18229476 SUBSTITUTED BENZO[5,6][1,4]DIAZEPINO[1,2-a]INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISORDERS WILLIS, DOUGLAS M 1624 Non-Final OA Aug 02, 2023
18054076 METHODS OF TREATMENT USING ANTI-CD123 IMMUNOCONJUGATES KIM, YUNSOO 1641 Non-Final OA Nov 09, 2022

Managing Immunogen Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month